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Abstract
Rotavirus is the leading agent causing acute gastroenteritis in young children, with the P[8]
genotype accounting for more than 80% of infections in humans. The molecular bases for
binding of the VP8* domain from P[8] VP4 spike protein to its cellular receptor, the secretory
H type-1 antigen (Fuc-α1,2-Gal-β1,3-GlcNAc; H1), and to its precursor lacto-N-biose (Gal-
β1,3-GlcNAc; LNB) have been determined. The resolution of P[8] VP8* crystal structures in
complex with H1 antigen and LNB and site-directed mutagenesis experiments revealed that
both glycans bind to the P[8] VP8* protein through a binding pocket shared with other mem-
bers of the P[II] genogroup (i.e.: P[4], P[6] and P[19]). Our results show that the L-fucose
moiety from H1 only displays indirect contacts with P[8] VP8*. However, the induced confor-
mational changes in the LNB moiety increase the ligand affinity by two-fold, as measured
by surface plasmon resonance (SPR), providing a molecular explanation for the different
susceptibility to rotavirus infection between secretor and non-secretor individuals. The unex-
pected interaction of P[8] VP8* with LNB, a building block of type-1 human milk oligosac-
charides, resulted in inhibition of rotavirus infection, highlighting the role and possible
application of this disaccharide as an antiviral. While key amino acids in the H1/LNB binding
pocket were highly conserved in members of the P[II] genogroup, differences were found in
ligand affinities among distinct P[8] genetic lineages. The variation in affinities were
explained by subtle structural differences induced by amino acid changes in the vicinity of
the binding pocket, providing a fine-tuning mechanism for glycan binding in P[8] rotavirus.
Author summary
The interaction of viruses with host glycans has become an important topic in the study of
enteric virus infectivity. This interaction modulates several aspects of the viral cycle,
including viral attachment, which in most cases depends on the host glycobiology dictated
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by the secretor and Lewis genotypes. The capacity to synthesize secretory type-I antigen H
(fucose-α1,2-galactose-β1,3-N-acetylglucosamine; H1) at the mucosae, dictated by the
presence of one or two functional copies of the fucosyl-transferase FUT2 gene (secretor
status), has been clearly linked to infectivity in important enteric viruses such as the noro-
viruses. However, a big controversy existed about the contribution of H1 antigen to infec-
tion in the leading cause of viral gastroenteritis in young children (rotavirus). It has not
been until recently that epidemiological data evidenced a diminished incidence of rotavi-
rus in non-secretor individuals unable to produce H1. In the present manuscript we offer
the evidence that P[8] RV bind H1 via a binding site common for the P[II] RV genogroup
and that the H1 precursor lacto-N-biose (galactose-β1,3-N-acetylglucosamine; LNB) is
also bound to this pocket with diminished affinity. The P[8] VP8� structures show a mar-
ginal role for the L-fucose moiety from H1 in protein interaction. However, its presence
provides conformational changes in the LNB moiety that increase the affinity of VP8� for
the H1 ligand and would account for a stronger RV binding to mucosa in individuals
expressing H1 (secretors). We thus offer a mechanistic explanation for the different inci-
dence of P[8] RV infection in different secretor phenotypes.
Introduction
Rotaviruses are the leading etiologic agent of viral gastroenteritis in infants and young children
worldwide and are responsible for an estimated 140,000 deaths each year in developing coun-
tries [1]. The typical classification of rotaviruses was derived from their genome composition
and the immunological reactivity of three of their structural proteins: VP6, VP7 and VP4.
Rotaviruses are classified into at least 7 groups (A to G) according to the immunological
reactivity of the VP6 middle layer protein, with group A rotavirus being the most commonly
associated with infections in human. The two outer capsid proteins VP7 and VP4, elicit neu-
tralizing antibodies that can induce viral protection. Using these two proteins, a traditional
dual classification system of group A rotaviruses into G (depending on the VP7 glycoprotein)
and P (depending on the protease-sensitive VP4) types was established [2]. At least 36 different
G-serotypes and 51 P-types have been identified among human and animal rotaviruses [3].
Viruses carrying G1[P8], G2[P4], G3[P8] and G4[P8] represent over 90% of human rotavi-
ruses strains co-circulating in most countries [2], with the P[8] genotype, which comprises
four different genetic lineages (I to IV [4]), being particularly relevant [5].
Diverse interactions between histo-blood group antigens (HBGAs) and rotavirus have been
described and it is believed that HBGAs expressed on the surface of target cells serve as viral
receptors. The distal VP8� portion (~27 kDa, N-terminal) of the rotavirus spike protein VP4
from P[8], P[4], P[6] and P[19] genotypes recognize the secretor HBGAs. P[8] and P[4] are
closely related genetically and both genotypes were reported to bind the Lewisb (Fuc-α1,2-Gal-
β1,3-[Fuc-α1,4-]GlcNAc; Leb) and H type-1 (H1) antigens (Fuc-α1,2-Gal-β1,3-GlcNAc) by
some authors [6], while there are controversial reports that show no Lewisb binding for these
genotypes [7]. P[6], a slightly further related genotype, binds the H1 antigen but not Lewisb
[6], whereas P[19] binds mucin core glycans with GlcNAc-β1,6-GalNAc motif and the type-1
HBGA precursor [8]. In addition, P[9], P[14] and P[25] genotypes bound specifically to the
type A antigens (GalNAc-α1,3-[Fuc-α1,2-]Gal)[9, 10], whereas P[11] interacted with single
and repeated N-acetyllactosamine (Gal-β1,4-GlcNAc; LacNAc), the type-2 precursor glycan
[11]. Detailed evidences of VP8�-HBGAs interactions has been obtained by X-ray crystallogra-
phy of P[14] VP8� and P[11] VP8� in complex with the type A oligosaccharide [9] and LacNAc
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[11], respectively. Recently, the structure of porcine P[19] VP8� complexed with lacto-N-fuco-
pentaose I (Fuc-α1,2-Gal-β1,3-GlcNAc-β1,3-Gal-β1,4-Glc; LNFPI), and the mucin core-2 oli-
gosaccharide (GlcNAc-β1,6-[Gal-β1,3] GalNAc) has been solved, showing a carbohydrate
binding pocket alternative to the one used by P[11] and P[14] [7]. This binding pocket was
first suggested by protein sequence analyses in other members belonging to the P[II] gen-
ogroup of rotaviruses (i.e. P[4], P[6], P[8] genotypes) [7] and recently confirmed for P[4] and
P[6] VP8�s [12]. However, why non-secretors individuals (lacking α1,2 fucosylation in secre-
tory HBGAs) have reduced rotavirus susceptibility [13–15] and what is the role of the secretory
L-fucose in H1 ligand recognition for the most relevant human rotavirus remains unknown,
as no structure was still available for the P[8] genotype in complex with ligand HBGAs. By
using VP8� from a clinical isolate belonging to the lineage III of P[8], in the present work we
show that P[8] VP8� binds H1 antigen at a similar site as their ligand HBGAs bind to P[19], P
[4] and P[6] genotypes. Our structural and functional results also show that the H1 precursor
lacto-N-biose (Gal-β1,3-GlcNAc; LNB), devoid of L-fucose, also interacts with VP8� and we
discard Lewisa or Lewisb antigens as ligands of P[8] genotypes. We provide the molecular
bases for the role of secretor antigen in rotavirus binding to its receptor. Our results show two-
fold increase in the affinity for the H1 antigen compared to LNB. This increase is explained by
reduced contacts of the L-fucose with solvent molecules and the structural stabilization of LNB
moiety in the competent conformation for binding. Furthermore, we show how subtle differ-
ences at the H1/LNB binding pocket in different P[8] lineages influence antigen affinities, giv-
ing clues for the relevance of the host glycobiology in P[8] rotavirus impact in humans. The
partial anti-adhesin effect of LNB against rotavirus reported in the present article and the
acquired knowledge on rotavirus-host cells interaction during virus attachment might open
new avenues for the treatment and prevention of rotavirus infections.
Results
The rotavirus VP8� domain from the P[8] genotype recognizes the H type-
1 antigen precursor lacto-N-biose
VP8� domains from P[4], P[6], P[9], P[11], P[14], P[25] genotypes and from different genetic
lineages (I, III and IV) from P[8] genotype were produced (S1 Fig). In order to confirm their
functionality, the different proteins were challenged by an ELISA-like binding assay against
a panel of biotinylated histo-blood group antigens (HBGAs) (Fig 1 and S1 Table), corroborat-
ing the previously described interactions (S2 Fig). Genotypes P[4], P[6] and P[8] recognized
the H type-1 antigen (Fuc-α1,2-Gal-β1,3-GlcNAc, H1), P[11] recognized the H type-2 antigen
(Fuc-α1,2-Gal-β1,4-GlcNAc, H2) and P[9], P[14] and P[25] the blood group A antigen trisac-
charide (GlcNAc-α1,3-(Fucα1,2)-Gal, Atri). The P[8] genotype additionally displayed low
binding to this trisaccharide. However, and contrarily to previous reports [7], in our assays
genotypes P[4] and P[8] exhibited very low or absence of binding to Lewisb (Fuc-α1,2-Gal-
β1,3-[Fuc-α1,4-]GlcNAc). Remarkably, VP8� from P[8] genotype recognize the H1 antigen
precursor lacto-N-biose (Gal-β1,3-GlcNAc, Lewisc, LNB; S2 Fig) but differences in the binding
abilities were found among different genetic lineages and strains. Thus, VP8� from the cultiva-
ble human rotavirus Wa (P[8]Wa) and the Rotarix vaccine (P[8]Rotarix) strains (both lineage I)
gave lower signals in the ELISA tests with H1 and LNB than the VP8� from the lineage IV
strain (P[8]LIV) and from a clinical isolate belonging to lineage III (P[8]c) (S2 Fig). The newly
discovered interaction with LNB was further characterized by testing different concentrations
of VP8� from this isolate (P[8]c) and the cultivable P[8]Wa (S3 Fig). The results showed that
both proteins were able to bind H1 and LNB, although binding to the first antigen was higher.
We performed a more detailed characterization of the interaction of VP8� to H1 and LNB by
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determining the apparent affinity constants (Kda) for each interacting pair by SPR (Table 1).
The Kda of the VP8
� P[8]c recognition of the H1 antigen (Kda = 27.9 ± 0.71 μM; Fig 2A) was
two-fold lower compared to the LNB precursor (Kda = 52.1 ± 4.26 μM; Fig 2B), this difference
Fig 1. Structure and schematic representation of the biosynthetic pathways of human type 1 and 2 histo-blood group antigens (HBGAs). The
structures the H1 and H2 antigens as well as their precursors LNB and LacNAc are shown.
https://doi.org/10.1371/journal.ppat.1007865.g001
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was significant (p = 0.0045) suggesting that the H1 L-fucose moiety contributes actively to the
binding. Surprisingly, the affinity constant for the interaction of VP8� from P[8]Wa with H1
was three times higher (Kda = 80.2 ± 2.21 μM) than that of P[8]c (Fig 2C). Furthermore, the
VP8� from P[8]Wa showed a similar apparent affinity for LNB than for H1 (Kda = 66.5 ±
6.47 μM; p> 0.05 Fig 2D). Interestingly, interactions for VP8� from Rotarix strain (lineage I)
and the lineage IV strain with H1 and LNB were too low to be determined under our SPR
conditions.
To further characterize the role of VP8� interaction with the H1 precursor LNB, complete
virions of the Wa strain (triple-layered particles; TLP) and double-layered particles (DLP;
obtained after VP4 and VP7 removal by EDTA treatment) were assayed by an ELISA-like
binding assay. The Wa TLP, but not the Wa DLP, were able to bind H1 antigen (Fig 3A) and
its precursor LNB (Fig 3B), in a concentration-dependent manner. This indicated that the
observed interaction between P[8] VP8� and LNB was also relevant in a complete rotavirus
context. These results also point to the fact that despite the low affinity of P[8] VP8� from line-
age I to H1 and LNB, the high avidity of a multi-binder particle (virions contain 120 molecules
of VP4) results in a measurable interaction.
Soluble lacto-N-biose and galacto-N-biose partially block the binding of
VP8� to H-type 1 antigen and to its precursor
To confirm the binding of VP8� from the P[8]c genotype to LNB we settled up a binding
blocking assay where LNB (Gal-β1,3-GlcNAc) and its structurally-related disaccharide
galacto-N-biose (Gal-β1,3-GalNAc; GNB), were tested as potential inhibitors of binding. The
results showed a moderate but significant (p< 0.05) reduction in the binding to the H1 anti-
gen by both disaccharides (24.2% reduction for LNB and 30.1% for GNB; Fig 4A). The mono-
saccharide constituents of LNB and GNB (D-galactose, N-acetyl-glucosamine and N-acetyl-
galactosamine) and L-fucose were also tested (Fig 4). Among these sugars only D-galactose
possessed a discrete but significant blocking capacity of VP8� binding to the H1 antigen
(14.7% reduction; p = 0.032). Interestingly, soluble L-fucose significantly increased the binding
of VP8� to the H1 antigen (Fig 4A). As expected, when the precursor LNB was used as the
ligand, soluble LNB and GNB were also able to reduce the binding of VP8� P[8]c, by 52.2%
and 44.1%, respectively (Fig 4B).
We next investigated the role of the H1 precursor antigen in rotavirus infection by incubat-
ing MA104 cells with rotavirus Wa strain that was preincubated with LNB, GNB, their mono-
saccharide constituents and L-fucose. Only LNB significantly blocked viral infection (33%
reduction; Fig 4C), suggesting that this HBGA precursor interferes with the binding of the
rotavirus Wa strain to its receptor in MA104 cells.
Table 1. Affinity constants between different VP8� proteins and HBGAs determined by SPR.
Analyte vs Ligand Kda (M)
a
P[8]c vs H1 2.79 x 10
−5 ± 7.17 x 10−7
P[8]c vs LNB 5.21 x 10
−5 ± 4.26 x 10−6
P[8]Wa vs H1 8.02 x 10
−5 ± 2.21 x 10−6
P[8]Wa vs LNB 6.65 x 10
−5 ± 6.47 x 10−6
P[8]c M4(Ile173Val) vs H1 3.90 x 10
−5 ± 1.25 x 10−6
P[8]c M4(Ile173Val) vs LNB 4.94 x 10
−5 ± 1.74 x 10−6
a Apparent affinity constant ± the standard deviation
https://doi.org/10.1371/journal.ppat.1007865.t001
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Glycans bind VP8� in a preformed binding pocket
To understand the molecular basis of LNB and H1 recognition and binding to P[8] VP8� we
determined the crystal structure of the clinical isolate P[8]c VP8
� in its apo form and bound to
LNB and H1 glycans. Two different crystalline forms of P[8]c VP8
� in its apo form were
obtained. The first form, VP8�-Apo1, diffracts at 1.35 Å resolution and presents a single copy
of P[8]c VP8
� in the crystal asymmetric unit (ASU) while the second form, VP8�-Apo2, dif-
fracts to 1.5 Å and presents two copies in the ASU (Table 2). The three copies of P[8]c VP8� in
these two crystalline forms present the galectin fold with two twisted β-sheets separated by a
superficial cleft that conforms the glycan binding site in P[11] and P[14] genotypes [9, 16] (Fig
5). Superimposition of the individual VP8� protomers from these crystals showed that the
three molecules of P[8]c VP8
� are almost identical (RMSD 0.28 Å for the superposition of all
the Cα; S4A Fig and S2 Table). Crystals of P[8]c VP8� bound to H1 or its precursor LNB were
obtained in a third different crystalline form and the structures of P[8]c VP8
�-H1 and P[8]c
Fig 2. Binding characterization of the H1 antigen and its precursor to VP8� from the P[8] genotype. Panel a shows the affinity fit and sensorgrams of the interaction
between P[8]c and the H1 antigen obtained by SPR. Panel b shows the affinity fit and sensorgrams of the interaction between P[8]c and LNB obtained by SPR. Panels c
and d show the affinity fit and sensorgrams of the interactions between P[8]Wa and the H1 antigen and P[8]Wa and LNB obtained by SPR, respectively. The bars indicate
the standard deviation.
https://doi.org/10.1371/journal.ppat.1007865.g002
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VP8�-LNB complexes were solved to 1.8 and 1.3 Å, respectively (Fig 6A, 6B and Table 2). Two
protomers of VP8� were present in the ASU of each of these crystals and, remarkably, only one
out of the two protomers showed a bound glycan molecule. Sugar binding induces negligible
conformational changes in the VP8� (S4A Fig) since the structural comparison of the glycan-
bounded and glycan-free P[8]c VP8
� protomers showed minimal differences (RMSD 0.22–
0.35 Å; S2 Table). Furthermore, P[8]c VP8� are also structurally identical (RMSDs 0.37–0.57
Å) to the VP8� apo forms of the linage I P[8]Wa and P[8]Rotarix (S4B Fig and S2 Table), support-
ing that the glycan binding site is preformed in the P[8]c VP8
� protein. This characteristic also
seems to be shared by other P genotypes belonging to the P[II] genogroup, since structural
comparison with recently reported glycan-bound structures of VP8� from human P[4] and P
[6], and porcine P[19] genotypes showed modest differences (RMSD 0.51–0.84 Å) (S4C Table
and S2 Table).
P[8] glycan binding site
P[8]c VP8
� binds H1 and LNB in a pocket formed by one of the β-sheets and the C-terminal α
helix (Fig 6A and 6B). The structures showed that the LNB moiety is embedded in the pocked
interacting with the protein while the L-fucose is projected out with minimal, mainly mediated
by solvent, contacts with the protein (Fig 6A and 6B). Only seven residues recognize the LNB,
contacting the N-acetyl-glucosamine moiety via L167, W174, T185, R209, and E212 and the
galactose moiety via T184, T185, E212 and N216 (Fig 6C, 6D and S3 Table). This pocket shared
identical interacting residues to the novel VP8� binding pocket recently discovered in P[19]
[7] and P[4]/P[6] [12] genotypes for their interaction with LNFPI and it differs from the previ-
ously defined carbohydrate binding site in VP8� from P[11] (LacNAc binding [11]) and P[14]
(A-antigen binding [9]) genotypes, that is located in the cleft between the two β sheets (S4D
Fig). The N-acetyl-glucosamine has a major contribution to the binding since it is inserted in
the pocket while the galactose acquires a more superficial position (Fig 6C and 6D). In this
way, the N-acetyl-glucosamine ring is packet between W174 and R209 that define two faces of
Fig 3. Binding of rotavirus particles to the H1 antigen and to lacto-N-biose (LNB). Rotavirus triple layered particles (TLPs) and double layered
particles (DLPs) were used in binding assays against the H1 antigen (panel a) and against its precursor (LNB) (panel b).
https://doi.org/10.1371/journal.ppat.1007865.g003
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the binding site and the O4 and O6 oxygens mediated hydrogen-bonds with E212 that it
placed at the bottom of the pocket (Fig 6C, 6D and S2 Table). To confirm the role of these
amino acids in H1 and LNB interaction, the P[8]c VP8
� mutants W174A (M1, VP8W174A),
R209A (M2, VP8R209A) and E212A (M3, VP8E212A) were obtained (S1 Fig). The three mutant
VP8� lost their ability to interact with their receptor when they were assayed for binding to H1
and LNB by SPR (S5 Fig), supporting the structural data and suggesting that the identified
pocket is the only binding site for H1 antigen and its precursor in P[8] VP8�.
Lacto-N-biose fucosylation and P[8] VP8� binding
Fucosylation of the H1 precursor is genetically determined by the FUT2 gene (α1,2 fucosyla-
tion of the terminal galactose), resulting in different secretor status and by the FUT3 gene
(α1,4 fucosylation at the precursor N-acetyl-glucosamine), defining the Lewis status (Fig 1).
This genetically determined glycan profile is a susceptibility factor in human rotavirus [17, 18].
Fig 4. Binding and infection blocking experiments. Soluble lacto-N-biose (LNB) and galacto-N-biose (GNB) as well as the monosaccharides L-fucose
(FUC), D-galactose, N-acetylglucosamine (GlcNAc) and N-acetylgalactosamine (GalNAc) were used at 20 mM to block the binding of VP8� from the
P[8]c genotype to the H1 antigen (panel a) and to LNB (panel b). The same sugars were utilized at 5 mg/mL to block the infection of Wa rotavirus in
MA104 cells. Statistical differences are indicated with asterisks. � p< 0.05; ��p< 0.01; ���p = 0.001 (panel c).
https://doi.org/10.1371/journal.ppat.1007865.g004
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Our P[8]c VP8� structure in complex with H1 antigen confirms that the secretory L-fucose
portion has reduced contacts with VP8� that are mediated by solvent molecules. Similarly,
minimal or null contacts of the L-fucose moiety were observed in the complexes of LNFPI
with other VP8� from the P[II] genogroup [7, 12]. Therefore, the difference in the affinity for
H1 and LNB in diverse VP8� from this genotype were difficult to explain. A close view of the
relative disposition of the precursor LNB moiety in both P[8]c VP8
� complexes after superim-
position of VP8� proteins showed some differences but not so for the interacting residues (Fig
7A). If, alternatively, the N-acetyl-glucosamine moieties from both structures are superim-
posed it becomes visible that the galactose moiety occupies a more solvent-exposed position in
the LNB structure compared to H1 (Fig 7B), explaining its weaker binding in comparison with
this antigen. The atomic resolution of the diffraction data and the high quality of the density
maps derived from these data (Fig 7C and 7D) allows modeling accurately the ligand struc-
tures to observe these differences. This observation indicates that the L-fucose moiety induces
an LNB conformation more suitable for the union to VP8�. The P[8]c VP8
� structure in com-
plex with H1 shows that the L-fucose ring stacks over the acetamido group of N-acetyl-glucos-
amine stabilizing the glycan conformation (Figs 6C and 7B). Therefore, the structures suggest
Table 2. Data collection and refinement statistics.
P[8]C VP8
� Apo1 P[8]C VP8
� Apo2 P[8]C VP8
� LNB P[8]C VP8
� H1
Data Collection
Beamline ALBA-XALOC ALBA-XALOC ALBA-XALOC ALBA-XALOC
Wavelength (Å) 0.97910 0.97907 0.97923 0.97928
Space group P32 2 P 21 21 21 P21 P21
Cell dimensions (Å) a = b = 76.15 c = 70.08
α = γ = 90 β = 120
a = 53.35 b = 77.74 c = 104.01
α = β = γ = 90
a = 38.99 b = 54.72
c = 67.43
α = γ = 90 β = 97.92
a = 38.74 b = 54.64
c = 67.94









Total reflections 524841 (27293) 483220 (61018) 220889 (26591) 85661 (12054)
Unique reflections 52269 (5152) 68175 (9712) 64030 (9582) 23811 (3447)
Completeness (%) 99.92 (99.34) 99.8 (98.9) 94.9 (97.6) 99.2 (98.9)
Multiplicity 10.0 (5.3) 7.1 (6.3) 3.4 (2.8) 3.6 (3.5)
Mean I/σ(I) 15.98 (1.48) 10.2 (2.3) 8.4 (1.7) 9.5 (1.9)
Rpim 0.021 (0.266) 0.051 (0.425) 0.053 (0.419) 0.053 (0.431)
CC 1/2 0.999 (0.932) 0.996 (0.802) 0.995 (0.739) 0.997 (0.746)
Refinement
Rwork 0.206 0.171 0.180 0.176
Rfree 0.227 0.204 0.209 0.232
Number of atoms 1564 3202 3204 2819
Protein 1312 2649 2652 2604
Water 211 524 512 179
Others 41 29 40 36
Rmsd, bonds (Å) 0.032 0.022 0.022 0.016
Rmsd, angles (˚) 2.703 2.224 2.105 1.717
Ramachandran plot
Preferred (%) 94.77 97.04 97.41 95.91
Allowed (%) 4.58 2.96 2.59 3.77
Outliers (%) 0.65 0 0 0.31
aNumbers in parentheses indicate values for the highest-resolution cell.
https://doi.org/10.1371/journal.ppat.1007865.t002
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that the L-fucose moiety could favor the VP8� binding by a double mechanism: inducing a
competent conformation that facilities the LNB module recognition and binding and mediat-
ing indirect interactions that stabilize the glycan-VP8� complex.
Oppositely, the fucosylation in the N-acetyl-glucosamine in the LNB precursor to produce
the Lewisb antigen seems to be incompatible with the binding to P[8] VP8�. Docking of the
Lewisb antigen (Fuc-α1,2-Gal-β1,3-[Fuc-α1,4-]GlcNAc) in the P[8]c VP8� structure taking H1
antigen as a reference showed that the α1,4-linked L-fucose points towards the inside of the
glycan binding pocket, clashing with different residues (mainly T185 and E212) that generate
this cavity (S6A Fig). Since glycan binding pocket is highly conserved among P[8] VP8� linages
and P[II] genotypes [7, 12], it seems that this group of rotaviruses are non-competent to bind
Lewis HBGAs. This observation is confirmed by our ELISA assays where any of the VP8� pro-
teins from P[II] genotype showed binding capacity to these HBGAs, and it questions previous
results were P[8] VP8� was shown to interact with Lewisb [6]. Following an identical approach
the A-type I antigen can be docked in the P[8]c VP8
� sugar-binding pocket. The docked sugar
showed that the N-acetylgalactosamine (GalNAc) added to the non-reducing end of the H1
galactose is pointing towards the solvent without showing any interaction with the protein
(S6B Fig), supporting that P[8] VP8� should be able to bind this sugar.
Fig 5. Structure of P[8]c VP8
�. a Cartoon representation of P[8]c VP8
� Apo1 with the secondary structural element are colored in blue for β-sheets, orange for α-
helices and white for loops. Different tones of blue are used to differentiate among β-strands. Secondary structural element are numbered and labeled in order from
the N to C terminus. The sequence of P[8]c VP8
� is shown in panel b, highlighting with red lettering the residues that interact with H1 sugar and with blue lettering
the β9-β10 hairpin. Magenta triangles indicate residues mutated in this study. Structural elements are shown above the sequence colored as in the cartoon
representation.
https://doi.org/10.1371/journal.ppat.1007865.g005
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Fig 6. Structures of P[8]c VP8
� in complex with H1 antigen and LNB. a Cartoon representation of P[8]c VP8
� H1 structure with β-strands in different pink tones to
differentiate among β-sheets, α-helices in cyan and loops in white. The H1 antigen bound between a β-sheet and the α-helix is shown in stick with carbon atoms in yellow,
green and slate blue for the GlcNAc, Gal and Fuc motives. b Cartoon representation of P[8]c VP8
� LNB structure in identical orientation with β-sheets in different orange
tones and α-helices in light-blue. The bound LNB is represented as in (a). c and d Close view of the P[8]c VP8� H1 (c) and P[8]c VP8� LNB (d) active centers. The bound
sugars are represented in sticks with atoms in yellow (GlcNAc), green (Gal) and slate blue (Fuc). The residues interacting with the sugars are shown in stick representation,
with carbon atoms colored according to the structural element to which they correspond (semi-transparent) and are labeled. Nitrogen and oxygen are colored in dark blue
and red, respectively. Waters interacting with the sugars are represented as orange (c) and cyan (d) spheres. The mutated I173 in the back side of the sugar binding pocket
is shown as stick in both panels.
https://doi.org/10.1371/journal.ppat.1007865.g006
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Subtle structural differences affect glycan binding affinity and specificity
The structures of VP8� in complex with LNB and H1 obtained here confirm that P[4], P[6], P
[19] and the prevalent human genotype P[8] of rotavirus share a common glycan binding site
Fig 7. Comparison of H1 and LNB sugar binding by P[8]c VP8�. a Close view of the glycan binding site of superimposed P[8]c VP8� H1 (light green) and P[8]c VP8�
LNB (light blue) structures (in semitransparent cartoon) showed that sugar interacting residues (in sticks and colored according to the corresponding structure) are
disposed with minimal differences in comparison with the corresponding bound sugars (in sticks and colored green and stale blue for H1 and LNB, respectively). b
Superimposition of the GlcNAc moieties of the H1 (in stick colored with carbons in green) and LNB (in stick colored with carbons in stale blue) from the structures of its
complexes with P[8]c VP8� shows that the galactose moiety in the LNB structure occupies a more shallow position. c and d The high quality electron density maps (2Fo—
Fc contoured in blue at 1σ) obtained by X-ray diffraction at 1.3 and 1.85 Å resolution for P[8]c VP8� in complex with LNB (c) and H1 (d), respectively, provides a high
level of details as shown for the modelled ligands represented in sticks (carbons, oxygen and nitrogen colored in green, red and blue, respectively) and the coordinated
molecules of solvent represented as red spheres inside the maps. P[8]c VP8
� proteins are shown as grey cartoons.
https://doi.org/10.1371/journal.ppat.1007865.g007
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which is highly conserved in structure and sequence. Therefore, the differences in affinity and
specificity for HBGAs observed in our ELISA and SPR assays as well as those reported by oth-
ers are striking. Particularly, the differences in the capacity to interact with the H1 antigen
observed among P[8] lineages are difficult to understand. Inspection of the amino acids defin-
ing the glycan binding site in the four P[8] lineages oriented by the comparison of the P[8]c, P
[8]Wa and P[8]Rotarix structures revealed interesting differences. First, the VP8
� protein from
Rotarix strain (lineage I) differed from other members of the same lineage, including the Wa
strain, by the replacement of leucine 167 by phenylalanine. Since L167 is placed at the bottom
of the sugar-binding pocket (Fig 6C and 6D), the introduction of a bulky Phe residue could
explain the lack of interaction of this vaccine strain to H1 [19] that was corroborated in our
study. Second, a close inspection of the P[8] structures revealed small differences in the dispo-
sition of the β-hairpin connecting the strands β9 and β10 (S7 Fig). These two β-strands define
the bottom of the glycan binding pocket where the LNB moiety is settled (Fig 6C and 6D).
These subtle movements are allowed by the presence of two Gly residues (G170 and G171)
conferring flexibility to the loop. Y169 and R172 at both sides of the Glys delimit the loop and
play a pivotal role in the correct organization of the binding pocket since Y169 stacks over
R209 and R172 interacts with W174, the main residues recognizing N-acetyl-glucosamine (Fig
6C, 6D and S7 Fig). Therefore, the disposition of this loop could modulate de glycan affinity
and specificity. The sequence analysis of this region among P[8] lineages reveals that at posi-
tion 173 lineage I presents a Val whereas an Ile is found in the rest of lineages (S4 Table). Posi-
tion 173 is placed in the base of the β-hairpin facing to the hydrophobic core of VP8� protein
(Fig 6C, 6D and S7 Fig). Therefore, we wondered if this subtle change could influence the gly-
can-binding site architecture accounting for the difference in the H1 affinities observed
between lineages. To test this possibility we designed a new mutant in which I173 in P[8]c
VP8� was replaced by Val (M4, VP8I173V), emulating P[8]Wa. This replacement resulted in a
VP8� with a diminished interaction with the H1 antigen, with an affinity constant (Kda =
39.0 ± 1.25 μM, S5 Fig, Table 1) 1.4-fold higher compared to the wild-type protein (Kda =
27.9 ± 0.71 μM, Table 1; p = 0.0002). The VP8I173V variant retained the binding ability to LNB
with an apparent affinity constant (Kda = 49.4 ± 1.74 μM, Table 1) that was still higher than
that of H1 (p = 0.0033). These results support that subtle amino acid changes at the loop close
to the binding pocket may have contributed to modulate the glycan affinity between P[8] VP8�
from lineages I and III. Differences at this site are also evident in the structures of VP8� from
the P[II] genogroup. While conservation between P[8] and P[4] is high, the sequence diver-
gence between P[4] and P[6] (S4 Table) might explain the different affinities for LNFPI
between these two genotypes [12].
Discussion
Virus-HBGAs interaction has emerged as an important factor in viral infectivity. Contrarily to
other enteric viruses (i.e.: norovirus), the relevance of HBGA interaction in rotaviruses was
first neglected, and virus-host cell attachment studies were mainly focused on binding to sialic
acid, until interactions with HBGA were suggested by VP8� structural analyses [20] and exper-
imentally determined in sialidase-insensitive strains [6]. In norovirus many studies point to
the human FUT2 polymorphism as a key feature affecting viral infectivity [17, 18]. Individuals
carrying two null FUT2 alleles lack fucosyl transferase-2 activity, do not express H antigen
structures at the intestinal mucosa and in secretions (non-secretors) and are less susceptible to
norovirus. While previous studies showed no correlation between the secretor status and rota-
virus infection [17], the most recent studies show that antibody titers to rotavirus [13], rotavi-
rus gastroenteritis incidence [14] and vaccine take [15] correlate with the FUT2 phenotype.
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However, the molecular mechanisms of these correlations were unknown until now. The
previously reported interaction of H1 antigen (Fuc-α1,2-Gal-β1,3-GlcNAc) with the most
common human rotavirus P genotype P[8] that has been further characterized here at the
structural level, highlights the importance of the secretor phenotype on the incidence of rotavi-
rus diarrhea. We have determined the characteristics of this interaction, acknowledging a new
binding site for H1 in VP8� common for all the members of P[II] genogroup. Our results
show that physical interaction between the H1 antigen and P[8] rotavirus occurs through the
precursor side of the molecule (LNB), reinforcing the idea that the main carbohydrate-protein
contacts are made via the N-acetyl-glucosamine moiety [7]. NMR studies on A-antigen bind-
ing of P[9] and P[14] VP8�, demonstrated that the L-fucose moiety does not make contacts
with VP8� and rather it remains exposed to the solvent with a high degree of flexibility [21].
However, in the same study VP8� from genotypes P[4] and P[6], that did not recognize A-anti-
gen in our assays, were shown to bind this antigen and L-fucose-protein contacts were evi-
denced [21]. Structural data from P[4] and P[6] VP8� in complex with LNFPI also showed a
limited but direct interaction of the α1,2-linked L-fucose with the protein, namely via the
R209 residue, which is conserved in all proteins from genogroup P[II] [12]. Due to the mini-
mal interaction of the secretory L-fucose to VP8�, the authors of this study hypothesize that
this glycan moiety has a low contribution to binding affinity and that a strong interaction
would be expected for the unfucosylated H1 precursor, explaining the epidemiological studies
that do not correlate the FUT2 status to infection by P[4] and P[6] genotypes [22]. Contrarily
to this, we show that although the L-fucose moiety of H1 makes indirect contacts with P[8]
VP8�, it stabilizes the competent conformation of the LNB moiety to interact with the sugar
binding residues, resulting in two-fold lower Kda for H1 compared to LNB. This small but sig-
nificative difference may be of relevance in the viral susceptibility context between secretors
and non-secretor (FUT2-/-) individuals. Furthermore, a weaker interaction to LNB may also
explain why infection of P[8] rotaviruses can occur, at a lower level, in non-secretor individu-
als [23] and it also accounts for the inhibitory effect of LNB in in vitro rotavirus infection
reported here.
The previously reported interaction of the P[8] genotype with Lewisb identified by ELISA
assays [6], could not be reproduced in our experiments. The structural evidence obtained here
and in the analyses of the P[4] and P[6] structures in complex with LNFPI [12] argues against
interaction with Lewisb, which differs with H1 in the presence of an extra L-fucose α1,4-linked
to N-acetyl-glucosamine that generates steric hindrances to the interaction. These discrepan-
cies, together with the differences found between ELISA and SPR for H1 binding in the differ-
ent P[8] lineages, suggest that simple qualitative ELISA tests do not always provide reliable
results and that other techniques need to be implemented in order to assess VP8� affinities for
HBGAs. However, structural data from P[4] and P[6] genotypes predict interaction with A-
and B-types HBGAs, as the N-acetyl-galactosamine (A-type) and galactose (B-type) located at
the non-reducing ends in these glycans do not make any steric hindrance [12]. This coincide
with our observation that P[8] VP8� from different lineages interact with blood group A trisac-
charide and it is also supported by modelling additional N-acetyl-galactosamine in H1 bound
to P[8]c VP8
� (S6 Fig).
We showed that variations in the binding domain in the P[8] lineages exist that justify the
differences in the affinity for H1 and LNB as measured by SPR. Additionally, even if the archi-
tecture of the binding site is similar for most P[8] lineages and other genotypes belonging to
the P[II] group, other protein residues outside this site may possess epistatic effects over the
capacity of the binding pocket to accommodate H1 and LNB, explaining the diverse affinities
among P[II] genotypes and in the different P[8] lineages. This is exemplified by the fact that
we were able to associate a residue that does not participate in direct protein-ligand contacts
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(Valine 173) in P[8]wa VP8
� to its lower affinity for H1 and LNB and that VP8� from the vac-
cine strain Rotateq (lineage II), although sharing identical key binding residues to lineage III,
do not bind H1 [19]. It is postulated that subtle changes in residues within and outside the
defined pocket leads to a fine tuning in HBGA affinities that may ultimately impact host infec-
tion capacity. Epidemiologic studies revealed the occurrence of P[8] lineages I, II and III as the
major circulating rotavirus with a prevalence of the lineage III [4, 24–26], while lineage IV is
rarely found [25]. It is worth mentioning that this lineage, which is phylogenetically distant
[4], carries some differences in the H1 binding pocket and showed low affinity to H1, has been
isolated from few countries but it seems to be rapidly expanding [27]. Many studies have
focused on the rotavirus genotypes circulating before and after the introduction of rotavirus
vaccination programs [28, 29], but no work addressed the question of whether a link exists
between the secretor status and the incidence of different P[8] lineages. In an study on the
effect of the FUT2 status on rotavirus gastroenteritis it was shown that 100% of the patients
(n = 51) were secretor positive compared to a healthy control or a group of non-rotavirus gas-
troenteritis patients (14–19% of non-secretors) and that all rotavirus involved were P[8] from
lineage III [30]. Studies on the dynamics of G1P[8] rotavirus in a western population showed
that ancient strains were Wa-like (lineage-I) and that new lineages emerged since late nineties
[4], although the three main lineages are co-circulating nowadays in most geographical loca-
tions. Some authors have argued that the lack of (or low) interaction of Wa-like strains to H1
may help these viruses to prevail, because they do not discriminate by the secretor status [21],
but our results suggest that only affinities for the receptor may be varying within the different
P[8] lineages and it is not known how this may impact viral fitness. Notably, the amino acids
comprising the H1/LNB binding pocket fall outside the defined epitopes in VP8� that elicit
protection (S8 Fig). Mutations in VP8� which result in antigenic variants that could escape
neutralizing antibodies are frequently isolated [24–26], but they are not affecting the H1/LNB
interacting residues defined here. The impact of the different rotavirus P[8] lineages in the
population depending on the secretor status deserves further studies in order to ascertain if the
prevalence or co-circulation of different P[8] lineages responds to an adaptation to the HBGA
profiles of the different hosts.
Despite the need for more exhaustive research on the relevance of HBGA and host specific-
ity/infectivity in P[8] rotavirus, surface glycans possess a clear application in the development
of antiviral strategies. It is established that human milk, in addition to other antiviral compo-
nents, carry a set of oligosaccharides (human milk oligosaccharides; HMO) that share struc-
tural similarities to HBGA [31] and could act as anti-adhesins by competition with pathogen
ligands at the mucosa. This blocking ability by soluble carbohydrates resembling rotavirus
ligands has been evidenced. HMO were shown to inhibit binding of VP8� from P[6] and P[11]
genotypes [32]; P[8] and P[4] genotypes infection is inhibited by the HMO 2’-fucosyllactose,
3’-sialyllactose and 6’-sialyllactose [33]; LNFPI inhibited infection of P[19], P[4], P[6] and P[8]
genotypes [7], while we showed that LNB inhibited infection of Wa strain in vitro. The anti-
adhesin potential of this simple disaccharide (LNB) is susceptible for being exploited in antivi-
ral strategies. LNB is present in human milk in its free form [34] but mainly as a building
block of type I HMO, which are predominant in human milk over type II HMO (based on Lac-
NAc), which are characteristic of other mammals and primates [31]. Thus, LNB has been con-
sidered the human milk ‘bifidus factor’, and many bifidobacterial species from the infant
gastrointestinal tract have the enzymatic machinery for its metabolism [35]. LNB would not
only act as a bifidobacteria-stimulating prebiotic but also as a viral anti-adhesin to counteract
rotavirus infection. Furthermore, its relatively simple synthesis, which can be undertaken
enzymatically and by metabolic engineering approaches [36], makes this disaccharide a candi-
date for the development of new functional foods (e.g. improved infant formula). In this
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respect, it is important to consider that high affinity constants (in the mM range) have been
determined for free oligosaccharides binding to VP8� [12, 21] and, in order to obtain good
competitors, conjugated multivalent oligosaccharides seem to be a better option.
Detailed determination of the interactions between viruses and their host is crucial to
develop appropriate antiviral strategies. We have defined the molecular interactions of P[8]
VP8� from human rotavirus with its ligand HBGA giving a physical explanation as to why the
secretor status influences rotaviral infectivity. Notwithstanding, extra structural elements
beyond the identified binding site in VP8� are probably responsible for modulating HBGA
interactions within P[8] lineages. Dissection of additional VP8� structural features affecting
ligand binding is under way.
Materials and methods
Expression and purification of rotavirus VP8� proteins
The VP8� (amino acids 64–224 from the VP4 protein of rotavirus) belonging to the P[4], P[6],
P[8], P[9], P[11], P[14] and P[25] genotypes were cloned into the, pGEX-2T, expression vector
(GE Healthcare) in order to express N-terminal GST fusions.
To amplify P[4], P[6], P[8], P[9] and P[14] VP8�s coding region, RNA was extracted from
human stool samples (collected at Hospital Clı́nico Universitario de Valencia) containing
rotavirus of known P genotype using the Trizol reagent following the standard procedure
(Invitrogen). Viral RNA was retro-transcribed using the SuperScript Reverse Transcriptase
(Invitrogen) and random-primers, and the cDNA was amplified by PCR using Pfu polymerase
(Stratagene) with primers detailed in S5 Table. The cDNAs were finally cloned into pGEX-2T
(GE healthcare) vector after digestion with BamHI (ThermoFisher). The VP8� genes from
genotypes P[4], P[11] and P[25] were purchased as synthetic genes from Gene-ART technolo-
gies (ThermoFischer). The expression level of the VP8� protein from the clinical sample P[4]
VP8� genotype was very low in E. coli and its codon usage was optimized. P[11] VP8� and P
[25] VP8� were not available as clinical samples. The recombinants GST::VP8� proteins were
expressed in E. coli BL21 (DE3) (Novagen) and purified by affinity chromatography using
GSTrap columns coupled to an ÄKTA prime FPLC system (GE Healthcare). All sequences are
included as fasta files in the supplementary data.
Site directed mutagenesis
Selected residues in the GST::VP8� P[8] were replaced for alanine or valine according to the
structural data of the LNB binding site. Four mutants (M1–M4) were constructed using a
Quick-Change site-directed mutagenesis kit (Stratagene) and appropriate oligonucleotides (S5
Table), and the DNA changes were confirmed by DNA sequencing. Mutant M1, M2 and M3
contained changes in the codons for tryptophan 174, arginine 209 and glutamic 212 residues,
respectively, that introduced an alanine at each position. Mutant M4 substituted isoleucine
173 by valine.
VP8 glycan binding assays
A panel of biotinylated sugar antigens including Lea, Leb, Lec (lacto-N-biose; LNB), H type-1,
H type-2 and blood group A and B trisaccharides were purchased from Glyconz (Fig 1 and S1
Table). These glycans are biotinylated neoglyconjugates of a poly[N-(2-hydroxyethyl)acrylam-
ide] (PAA) with a size from 30 to 50 KDa. This forms a flexible polymer ideal for a multivalent
presentation of glycans. Immobilized streptavidin F96 black plates (Nunc) were coated with
the biotinylated oligosaccharides (2 μg/ml) in milli-Q water and incubated during 1 hour at
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37˚C. After functionalization the plates were washed once with PBS containing 0.05% of
Tween 20 (PBS-T) and the VP8� proteins were added (10 μg/ml) and incubated at 4˚C over-
night. After three washes with PBS-T, a rabbit polyclonal antibody anti GST (1:1,000) (Abcam)
was added and the plates were incubated one hour at 37˚C. Then, the plates were washed three
times with PBS-T and incubated for 1 h at 37˚C with 1:10,000 dilution of horseradish peroxi-
dase (HRP)-conjugated goat anti-rabbit (Abcam). After three washes with PBS-T, the binding
was detected using QuantaBlue reagent (ThermoFisher) kit, as recommended by the manufac-
turer. Fluorescence units were registered by a MultiScan microplate reader. All the binding
assays were performed in triplicate.
The EC50 binding of the VP8
� from the clinical (P[8]c) and Wa (P[8]Wa) genotypes to the H
type-1 and to its precursor (LNB, Lec) was determined incubating two fold serial dilutions of
the VP8� proteins, ranging from 100 μg/ml to 1.5 μg/ml. The binding assays were performed
in triplicate using the protocol described above.
Binding blocking assays
To confirm the binding of the VP8� from the P[8] genotype to the H type-1 precursor LNB, a
blocking assay was performed using soluble LNB and its related disaccharide galacto-N-biose
(Gal-β-1,3-GalNAc; GNB) produced and purified in our laboratory as previously described
[36].
Streptavidin microtiter plates were coated with biotinylated H type-1 antigen or LNB at
2 μg/ml with water and incubated for 1 hour at 37˚C, followed by an overnight incubation at
4˚C. Blocking assays were performed in parallel, using glass tubes containing the P[8]c and P
[8]Wa VP8
� protein at their EC50 for each ligand and 20 mM of each of the soluble disaccha-
rides (LNB and GNB) and monosaccharides (D-galactose, GlcNAc and GalNAc). A positive
binding control without sugar was also included. The tubes containing the mixes of VP8� with
sugars were maintained 1 hour at 37˚C, followed by an overnight incubation at 4˚C. The next
day the coated streptavidin plates were washed with PBS-T, the VP8�-sugar solutions were
added to the plates and incubated during 4 hours at 4˚C. The plates were washed three times
with PBS-T and detection of the interactions was performed as described above. The results
are presented as the percentage (%) of binding of each condition compared to the binding of
the positive binding control (without blocking sugar). All experiments were performed in
triplicate.
Production of rotavirus particles
African green monkey kidney epithelial cells (MA104 cell line; ATTC #CRL-2378.1) were used
for the propagation of rotavirus Wa strain that belongs to the globally dominant human geno-
type G1P[8]. Briefly, ten MA104 cells confluent 150-cm2 flasks (approximately 1.5 ×107 cells/
flask) were infected with Wa strain at a multiplicity of infection (MOI) of� 0.1 and processed
as previously described [37]. One hundred ml of medium with 1.5x108 virus/ml were obtained
and the viral particles were concentrated by pelleting at 160,000 × g for 1 h at 4˚C in a SW 41
rotor (Beckman). The viral pellet was resuspended in TNC buffer (20 mM Tris-HCl pH 8.0,
100 mM NaCl, 1 mM CaCl2) for triple-layered particles (TLP) or in TNE (20 mM Tris-HCl,
pH 8.0, 100 mM NaCl, 1 mM EDTA) for double-layered particles (DLP).
Rotavirus triple-layered (TLP) and double-layered particles (DLP) glycan
binding assays
An ELISA-like binding assay was employed to determine the binding ability of rotavirus TLP
and DLP to the H type-1 antigen and to its precursor LNB. Streptavidin plates were coated
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with the biotinylated oligosaccharides as described above. After washing with PBS-T, two fold
serial dilutions of TLPs and DLP were added to the plate (ranging from 10 μg/ml to 0.078 μg/
ml). The TLP were always maintained in TNC-T (20 mM Tris, 100 mM NaCl, 1 mM CaCl2,
0.05% Tween 20, pH 7,4) buffer and the binding and washing steps were always carried out in
this solution. DLPs assays were carried out in Tris-buffered saline buffer with Tween 20
(TBS-T, 20 mM Tris, 100 mM NaCl, 0.05% Tween 20, pH 7.4). TLP and DLP were incubated
in the plate overnight at 4˚C. After binding, the plates were washed three times in TNC-T (for
TLP) or TBS-T (for DLP) with 0.05% Tween 20 (TNC-T and TBS-T), and a mouse anti-VP6
antibody was added at 1:100 in TNC-T or TBS-T and incubated 1 h at 37˚C. The plates were
then washed three times with TNC-T or TBS-T, and a HRP-conjugated anti-mouse IgG was
added at 1:10.000 and incubated at 37˚C for 1 h. After three final washes the binding was
revealed by QuantaBlue reagent (ThermoFisher) following the manufacturer recommenda-
tions. Fluorescence units were recorded by a MultiScan microplate reader.
Blocking of rotavirus infection in MA104 cells
The G1P[8] Wa strain was tested on MA104 cells. The sugars LNB, GNB, GlcNAc, GalNAc,
D-galactose and L-fucose were tested for their effect on rotavirus infectivity. The oligosaccha-
rides were previously heat sterilized at 99˚C for 10 min and then dissolved in serum-free
DMEM containing 1 μg/ml trypsin. Serum-free DMEM containing 1 μg/ml without oligosac-
charide was used as a control in each experiment.
The effect of different mono- and disaccharides on rotavirus infectivity was assessed
through standard fluorescent focus assays on MA104 cells [37]. The dilution of Wa virus stocks
that yielded ~150 focus-forming units/well was first established. Then, sugars were added dur-
ing virus inoculation at a final concentration of 5 mg/ml, incubated for 1 hour, and unbound
virus was removed by washing with FBS-DMEM. The cells were allowed to be infected for
16h, washed once with PBS and fixed with 100% methanol. A mouse anti-VP6 primary anti-
body (1:50 dilution in PBS containing 3% BSA) was added and incubation proceeded for 30
min at room temperature with gentle rotation. A secondary antibody anti-mouse IgG-FITC
(Sigma F4143) diluted 1:128 in PBS containing 3% BSA was added and incubated for 30 min
at room temperature with gentle rotation. Individual fluorescence foci were counted on an
inverted fluorescence microscope with a FITC-compatible filter. Infectivity in the absence of
oligosaccharides served as the control. Each experimental condition was tested a minimum of
2 times, with technical triplicates for each oligosaccharide. The means and SD from a mini-
mum of 6 determinations are represented for each condition. Virus titer measured in the
absence of oligosaccharides was considered to be 100% infectivity, and changes in virus titer in
the presence of sugars were expressed as percentage of infectivity compared with no sugar
treatment.
Surface plasmon resonance (SPR) analysis
The affinity assays were based on SPR and performed in a Biacore T100 instrument (GE
Healthcare). H1 PAA-biotin and LNB PAA-biotin were diluted to a concentration of 1 mg/ml
in water and captured with streptavidin present in a SA sensor chip (GE Healthcare). H1 was
immobilized in channel 2 (630 RU) of the sensor chip and LNB was immobilized in channel 4
(624 RU). The channels 1 and 3 were used as the reference surfaces for channels 2 and 4,
respectively. The immobilization process was performed by conditioning the sensor chip sur-
face with three consecutive 1-minute injections of 1 M NaCl 50 mM NaOH before biotinylated
ligands were immobilized at a flow rate of 15 μl/min. The affinity assays of VP8� polypeptides
to biotinylated sugars were performed at 10˚C using 1X HBS-EP+ buffer (0.01 M HEPES pH
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7.4, 0.15 M NaCl, 3 mM EDTA, 0.005% Surfactant P20), a flow rate of 5 μl/min with 2700 sec-
onds of contact time and a dissociation time of 1800 seconds. The regeneration step consisted
in a wash step with 10 mM Glycine-HCl pH 2 for 20 seconds at the same flow rate. The assays
were performed with purified VP8� at different concentrations (45; 137; 411; 1,234; 3,703;
11,111; 33,333; 100,000 and 200,000 nM). Each run included three blanks without sample. The
affinity data were obtained after analysis of sensorgrams performed with the BIAevaluation 2.0
software (GE Healthcare). Since multivalent oligosaccharides are immobilized on a sensor
chip surface, avidity and rebinding effects can take place and apparent affinity constants (Kda)
are calculated with this experimental setup. Kda values were obtained from the steady-state
kinetics experiment as the ligand concentration needed to achieve a half-maximum binding at
equilibrium. The experiments were made in triplicate. Graphical representation of signal/con-
centration curves were plotted using GraphPad Prism 6 for MacOsX.
Crystallization and data collection
The crystals were grown as hanging drops at 21˚C with a vapour-diffusion approach. Initial
crystallization trials were set up in the crystallogenesis service of the IBV-CSIC using commer-
cial screens JBS I, II (JENA Biosciences) and JCSG+ (Molecular Dimensions) in 96-well plates.
Crystallization drops were generated by mixing equal volumes (0.3 μl) of P[8]c VP8� protein
solution and the corresponding reservoir solution, and were equilibrated against 100 lμl reser-
voir solution. Both P[8]c VP8
� Apo structures were crystallized at 10 mg/ml. VP8� Apo1 was
crystallized in a reservoir solution of 1.2 M (NH4)2SO4, 3% iso-propanol and 0.1 sodium cit-
rate pH 4.6, whereas VP8� Apo2 was crystallized in 1.5 M Li2SO4 and 0.1 M Tris-HCl pH 6.5.
In both cases 2 M Li2SO4 was used to cryoprotect the crystal when freezing in liquid nitrogen.
For the crystallization in presence of glycans, the ligands were mixed with the protein at 10 mM
final concentration of ligand and 10 mg/ml of protein final concentration. P[8]c VP8
� LNB was
crystallized in a reservoir solution consisting in 25% PEG 3,350 0.1 M Bis-Tris pH 5.5. The cryo-
solution used for crystal freezing was its reservoir solution increased up to 35% PEG 3,350. P
[8]c VP8
� H1 was crystallized against a a reservoir solution consisting in 25% PEG 6,000, 0.1 M
Na-HEPES pH 7.5, 0.1 M LiCl, and PEG 6,000 was increased up to 35% for cryoprotection. X-
ray diffraction was carried out at 100K at Alba (Cerdanyola, Barcelona, Spain) and DLS (Didcot,
UK) synchrotrons and the best data sets used to solve the structures were collected at the indi-
cated beamlines and wavelengths (Table 2). Diffraction data was processed and reduced with
Mosflm[38] and Aimless[39] programs from the CCP4 suite [40]. The data-collection statistics
for the best data sets used in structure determination are shown in Table 2.
Model building
P[8]C VP8
� Apo1 structure was solved by molecular replacement carried out with the program
Phaser [41] and using the structure of VP8� from CRW-8 porcine rotavirus (PDB 2I2S[20]) as
a model. Initial phases from the molecular replacement were used to manually build the P[8]c
VP8� structure with Coot [42]. P[8]c VP8
� Apo1 structure was then used as a model for molec-
ular replacement to solve the P[8]c VP8
� Apo2, P[8]c VP8�LNB and P[8]c VP8
�H1 structures.
All the final models were generated by iterative cycles of refinement using the Refmac [43] and
manually optimization with Coot. Data refinement statistics are given in Table 2. The crystals
exhibited good quality control parameters and excellent stereochemistry. Atomic coordinates
and structure factors have been deposited in the Protein Data Bank (PDB) with ID numbers
6H9W, 6H9Z, 6H9Y and 6HA0 for P[8]c VP8
� Apo1, P[8]c VP8
� Apo2, P[8]c VP8
�LNB and P
[8]c VP8
�H1, respectively. Structure Superposition and RMSD calculations were carried out
with Superpose [44] from CCP4 suite.
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Statistical analysis
To assess statistical differences in the ELISA-like binding experiments where many groups
were compared an ANOVA test was performed. To analyze significative differences in the Kda
values obtained by SPR an unpaired t-test was applied. All statistical analyses were performed
with GraphPad Prism version 6.0 for MacOsx (GraphPad Software). p values <0.05 were con-
sidered to be statistically significant.
Ethics statement
This study was conducted with the approval of the Ethics Committee of the University of
Valencia (code H1544010468380).
The human stool samples from Hospital Clı́nico Universitario de Valencia were anon-
ymized previously to their inclusion in the present study.
Supporting information
S1 Fig. Coomassie blue stained 12% SDS-PAGE gel showing the different GST::VP8� pro-
teins used in the present study. The genotype of each one of the proteins is indicated as well
as the molecular weight marker (Mw). The molecular weights (in kDa) of the marker are indi-
cated at the right of the gel. The P[8]Wa corresponds to the lineage I and the P[8]c corresponds
to the lineage III strain RVA/Human-wt/VLC/3455/2015/[G1P8]. Lineage IV correspond to
strain RVA/Human-tc/BGD/MMC71/2005/G1P[8].
(PPTX)
S2 Fig. ELISA-like binding assays of rotavirus VP8� from different genotypes to a panel of
biotinylated sugars. The interaction pairs are indicated in each panel from panel a to panel j.
(PPTX)
S3 Fig. Characterization of the interaction of P[8]c and P[8]wa VP8
�s to the H1 antigen
and LNB by ELISA. The graph shows the concentration-dependent binding of VP8� from the
clinical isolate (P[8]c) and from the cultivable Wa strain (P[8]Wa) to the H1 antigen and to its
precursor lacto-N-biose (LNB).
(PPTX)
S4 Fig. P[8]c VP8
� has a preformed sugar binding pocket coinciding with the observed in
viruses of the same genogroup but differing from the observed in other genogroups. a The
backbone structures of P[8]c VP8
� in its apo form (Apo1 and Apo2 in orange and magenta,
respectively), and in complex H1 (green) and LNB (blue) are superimposed. The glycans
bound to P[8]c VP8
� are shown in stick representation with carbon atoms colored according
to the corresponding structure. b Superposition of the backbone structures of P[8]c VP8
� H1
(green) with VP8� apo forms of the linage I P[8]Wa (magenta; PDB 2DWR[20]) and P[8]Rotarix
(blue; PDB 5JDB[19]). H1 glycan is shown in sticks with carbon atoms colored in green. c
Superimposition of VP8� structures form different members of PII genogroup. The backbones
structures of VP8� proteins in its apo form from P[8]Wa (magenta; PDN 2DWR[20]) and P
[8]Rotarix (blue; PDB 5JDB[19]) or in complex with different glycans from P[8]c (green), P[19]
(orange; PDB 5VKS[7]), P[6] (cyan; PDB 5VX9[12]) and P[4] (gray; PDB 5VX5[12]) are
superimposed and the bound glycans (H1 or LNFPI) are shown in stick representation with
carbon atoms colored according to the corresponding structure. d Superimposition of back-
bone structures of P[8]c VP8
� (green), P[14] VP8� (pink; PDB 4DS0[9]) and P[11] VP8� (light
blue; PDB 4YG0[16]) bound to H1, A-type and LNnT glycans (in sticks), respectively, shown
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that sugar biding pocket localization differ between genogroups.
(PPTX)
S5 Fig. Characterization of the interaction of M1, M2, M3 and M4 VP8�mutant variants
with the H1 antigen and lacto-N-biose (LNB) by SPR. a to f Lack of binding of mutants M1
to M3 to the H1 antigen (a, c and e) and to LNB (b, d and f), confirming the functionality of
the VP8� binding pocket. g and h show binding and obtained Kda of the M4 mutant (Ile175Val
P[8]c) to H1 and LNB, respectively.
(PPTX)
S6 Fig. Structural evidences of P[8]c VP8
� sugar selectivity. Modeling of the Lewisb (a) and A-
type (b) antigens in P[8]c VP8� H1 structures shows that the Lewisb Fuc (in sticks with carbon
atoms colored in cyan) is projected from the H1 glycan (in sticks with carbon atoms in green)
towards the VP8� protein (in stale blue carton highlighting the protein surface in white semitrans-
parent representation) clashing with different sugar recognizing residues as T185 and E212. In the
case of the A-type I antigen, the presence of an additional GalNAc moiety (in sticks with carbon
atoms colored in magenta) has not steric problems since it is project towards the solvent.
(PPTX)
S7 Fig. Minimal movements induced by sugar binding to P[8] VP8�. The structures of P
[8]Wa (pink; PDN 2DWR[20]), P[8]Rotarix (light blue; PDB 5JDB[19]) and P[8]c (orange) in its
apo forms are superimposed with P[8]C in complex with H1 (green) and the backbone of the
structural elements conforming the glycan binding site are shown. The bound H1 antigen is
represented in sticks with carbon atoms in yellow (GlcNAc), green (Gal) and slate blue (Fuc).
The residues interacting with the sugars are shown in stick representation, with carbon atoms
colored according to the structural element to which they correspond. Oxygen and nitrogen
atoms are colored in red and dark-blue, respectively, in all the structure. A subtle displacement
of the loop connecting β9-β10 strands between the glycan free and glycan-bound forms is
observed and indicated by and around. Similar displacement is observed in the ligang-binding
residue Y169. The loop displacement is facilitated by the presence of two Gly (G170 and G171)
residues represented as spheres. The hydrophobic residue (Val or Ile) in the backside of the
glycan binding pocket at position 173 is shown as stick.
(PPTX)
S8 Fig. Sugar recognizing residues are not antigenic. Two surface representations of P[8]c
VP8� rotated 180˚ are shown highlighting the position of the antigenic residues in Rotarix and
RotaTec strains in red and the sugar binding residues in cyan. The H1 sugar is represented in
sticks with carbon atoms in yellow (GlcNAc), green (Gal) and slate blue (Fuc).
(PPTX)
S1 Table. Biotinylated oligosaccharides utilized in the present study. All biotinylated oligo-
saccharides were purchased from Glyconz.
(PPTX)
S2 Table. RMSD values for the superposition of all the Cα atoms of VP8� structures from
different P[II] genogroup rotavirus (Apo or glycan bound).
(PPTX)
S3 Table. Contacts between the precursor LNB and H1 trisaccharide ligands with the VP8�
protein from P[8]c.
(PPTX)
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S4 Table. Comparison of the amino acid positions involved in H1 and LNB binding in dif-
ferent P[8] lineages of VP8�. Residues critical for H1 and LNB interaction were determined
in P[8]c VP8
� (lineage III). The residues that were mutated to alanine (174, 209 and 212) are
shown in bold. The underlined residue (position 173) does not make ligand contacts but dif-
fers between lineage I and lineages II, III and IV.
(PPTX)
S5 Table. Primer sequences utilized in the present work. BamHI restriction site is under-
lined.
(PPTX)
S6 Table. Sequences of the different VP8� in fasta format.
(PPTX)
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